Low frequency of allelic loss in skin tumours from immunosuppressed individuals
1997

Low Frequency of Allelic Loss in Skin Tumours from Immunosuppressed Individuals

Sample size: 128 publication Evidence: moderate

Author Information

Author(s): I Rehman, AG Quinn, M Takata, AEM Taylor, JL Rees

Primary Institution: Department of Dermatology, University of Newcastle upon Tyne, Newcastle upon Tyne, UK

Hypothesis

Tumours from immunosuppressed individuals have a different molecular pathogenesis compared to those from immunocompetent individuals.

Conclusion

Tumours in immunosuppressed individuals show a significantly lower rate of loss of heterozygosity than those in immunocompetent individuals.

Supporting Evidence

  • Immunosuppressed individuals had a lower rate of loss of heterozygosity in their tumours compared to immunocompetent individuals.
  • 20 out of 148 tumours from immunosuppressed individuals showed loss of heterozygosity, compared to 157 out of 428 in immunocompetent individuals.
  • The study suggests a different molecular pathogenesis for tumours in immunosuppressed patients.

Takeaway

People who have received organ transplants and take medicine to suppress their immune system have different skin cancer tumors than those who don't.

Methodology

The study compared the rate of loss of heterozygosity in skin tumours from immunosuppressed patients and immunocompetent individuals using DNA analysis.

Participant Demographics

12 immunosuppressed patients (organ transplant recipients) and 68 immunocompetent individuals.

Statistical Information

P-Value

0.0001

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication